logo
logo
Sign in

Proton Pump Inhibitors Market Growth is Accelerated by Increasing Prevalence of GERD and Peptic Ulcers

avatar
Purvaja
Proton Pump Inhibitors Market Growth is Accelerated by Increasing Prevalence of GERD and Peptic Ulcers

Proton pump inhibitors are drugs that work by reducing the amount of acid produced in the stomach. They are used to treat acid reflux, ulcers, and other conditions caused by excess stomach acid. Some common PPI medications include omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole. PPIs provide effective relief from symptoms of acid-related disorders and allow stomach ulcers to heal. Their effectiveness and safety profile have led to widespread use for conditions like gastroesophageal reflux disease and peptic ulcers. The global Proton Pump Inhibitors Market is estimated to be valued at US$ 3.29 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends driving the growth of the proton pump inhibitors market is the increasing prevalence of GERD and peptic ulcers. GERD, commonly known as acid reflux, is a common condition where stomach acid backs up into the esophagus. It affects as many as one in five Americans and is more common among older adults. Peptic ulcers, which are sores that develop on the lining of the stomach or small intestine, also occur frequently due to excess stomach acid. PPI drugs are very effective at reducing stomach acid production and allowing these conditions to heal. Their widespread use to treat disorders associated with excess stomach acid has contributed significantly to the increasing demand and growth of the proton pump inhibitors market.

Segment Analysis

The global proton pump inhibitors market is dominated by the pharmaceutical segment. This segment accounts for over 70% of the overall market share owing to the higher acceptance of PPI drugs for treating acid-related gastrointestinal disorders. Pantoprazole sodium's sub-segment holds the largest share within the pharmaceutical segment due to its higher efficacy and longer duration of action compared to other PPI drugs.

Key Takeaways

The Global Proton Pump Inhibitors Market Share is expected to witness high growth during the forecast period.

Regional analysis: North America is expected to continue dominating the proton pump inhibitors market during the forecast period. The rising prevalence of gastrointestinal diseases coupled with the rising geriatric population in the US and Canada is driving the growth of the regional market. Moreover, the presence of several key players in the region is also contributing to its large share.

Key players: Key players operating in the proton pump inhibitors market are Koninklijke TenCate (Netherlands), Low & Bonar (UK), Fibertex Nonwovens (Denmark), Thrace Group (Greece), Huesker (Germany), Berry Global (US), DuPont (US), Strata Systems (US), Leggett & Platt (US), Officine Maccaferri (Italy), GSE Environmental (US), Kaytech (South Africa), Mattex (Saudi Arabia), NAUE (Germany), Propex Operating Company (US), Carthage Mills (US), and Asahi Kasei Advance Corporation (Japan), among others.

For more details on the report, Read- https://www.insightprobing.com/proton-pump-inhibitors-market-demand-and-overview/

collect
0
avatar
Purvaja
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more